Jonathan Adly

Founder TJM labs | AI Engineer & Pharmacist | Building AI Solutions for Healthcare & Beyond

[Jonathan Adly @Jonathan_Adly_]

@ottosipe @rrhoover @AbudBakri @hubermanlab Ingredients + telehealth + pharmacy margins.

Right now- it’s website to patient. When it is legit, you will yet at a minimum a couple of business in the middle.

Probably would stay the same so long as it is stigmatized & only limited # of pharmacies and telehealth are intereste

[Jonathan Adly @Jonathan_Adly_]

@tjparker He did Reta and screwed up there. This specific scenario is very common for high-dose Reta.

It is well-documented in the peptide circles.

Incredibly difficult to actually get that far with the current GLP1s.

[Jonathan Adly @Jonathan_Adly_]

@ottosipe @akiffpremjee You guys behind this @ottosipe? It is a very neat feature

[TJM Labs @TJM_Labs]

@asembiarx 2026 is here 👇

Most pharmacy teams don’t have a capacity problem.
They have a workflow problem.
That’s where TJM Labs is focused.

https://t.co/7arShFomQt
#Asembia26
@Jonathan_Adly_

[TJM Labs @TJM_Labs]

TJM Labs has acquired Encore Rx Automation.

Expanding our capabilities for independent and retail pharmacies with faster deployments and broader PMS support.

More: https://t.co/vMcLPvOntm

#PharmacyAutomation #AIinPharmacy

[Jonathan Adly @Jonathan_Adly_]

@maxmarchione I have 200+ of the my biggest ones as our customers. Dm are open

[Jonathan Adly @Jonathan_Adly_]

We have this a week away from production.

[Tom Blomfield @t_blom]

Pretty soon, I think we’ll see software shipping with Claude Code SDK embedded inside.

Users will use it to configure and modify the software to meet their exact needs.

The best changes will get passed back to the software developer and reincorporated in the master release.

[TJM Labs @TJM_Labs]

Most AI in pharmacy is overhyped. But some of it is very real.

We break it down in this @a4pcrx podcast episode.

📷 Podbean: https://t.co/iCP9TGMHxf

📷 Apple Podcast: https://t.co/FTe1HZIdXQ

📷 Spotify: https://t.co/F2eTrkownS

#Pharmacy #AIinHealthcare #HealthcareOps

[Jonathan Adly @Jonathan_Adly_]

@nikillinit Skill issue - we scaled to almost 5m arr with Linkedin outbound as main GTM motion

[TJM Labs @TJM_Labs]

We’re exhibiting at #AtriumX 2026 in Orlando next week!

Looking forward to meeting pharmacy owners & innovators at this collaborative, action-focused event.

Come by our booth to see how @TJMLabs is advancing solutions in pharmacy tech.

[TJM Labs @TJM_Labs]

From the NCPA (@Commpharmacy) Multiple Locations Conference 🎥

TJM Labs VP of Sales Ross Miller joins Cole Thomas of @ConnexionRx to explain how TJM Labs helps pharmacies improve workflow and efficiency.

#NCPA #HealthTech

[TJM Labs @TJM_Labs]

TJM Labs is now the official automation partner of Professional Compounding Centers of America (@pccarx).

Bringing intelligent workflow optimization to compounding pharmacies nationwide.

https://t.co/4bib4tiS2T

#CompoundingPharmacy #PharmacyAutomation

[Jonathan Adly @Jonathan_Adly_]

@simonw Code used to be expensive, now it is cheap.

Domain expertise and distribution are still expensive - and you can argue that they are more expensive now.

[Jonathan Adly @Jonathan_Adly_]

@_simonsmith There is a sweetspot when this will indeed be the case.

Like you won’t do it with Figma so you 8 designers can save $299/month.

But some shitty SOR that charges $300k to store records? Yea, it is worth it.

[Jonathan Adly @Jonathan_Adly_]

THERE IS A WHOLE THREAD OF THOSE Ads ☠️

[Claude @claudeai]

Ads are coming to AI. But not to Claude. Keep thinking.

[Jonathan Adly @Jonathan_Adly_]

Anthropic woke up and chose violence with this ad 💀

[Tom Warren @tomwarren]

Anthropic just took a big swipe at OpenAI's decision to put ads in ChatGPT. Anthropic is airing ads mocking ChatGPT ads during the Super Bowl, and they're hilarious 😅 Anthropic is also committing to no ads in Claude https://t.co/LR1v4xz9ds

[Jonathan Adly @Jonathan_Adly_]

We have an X company account now: @TJM_Labs 🙌

[Jonathan Adly @Jonathan_Adly_]

@thaAdamLittle Salesforce vs. Veeva in life sciences is a massive battle

[Jonathan Adly @Jonathan_Adly_]

Great interview

[John Collison @collision]

Dave Ricks has been at @EliLillyandCo for 20% of its 150-year history. He came to the pub, poured his own Guinness, and gave us a 2-hour state of the pharma union: drug prices, clinical trials, patent clocks, the rise of generics, Chinese peptides, compounding pharmacies, the US healthcare system, and how the broad success of GLP-1s have transformed Lilly's business. If you've never heard Dave speak before, you're in for a treat.

Timestamps:
00:00 Intro
05:08 Making R&D decisions
10:11 Clinical trials
24:59 Drug pricing
32:43 Stimulating more R&D
45:16 Pros and cons of US healthcare
58:20 New pharma business models
01:05:53 Stripe + enterprises
01:07:00 China
01:16:31 Generics
01:22:37 GLP-1s
1:37:43 r/Peptides
01:41:25 LillyDirect
01:46:35 Why do investors love LLY?

[Jonathan Adly @Jonathan_Adly_]

One of my competition is basically this - I love it, and happy for them to live the good life

[Ankur Nagpal @ankurnagpal]

We need a word for a very specific type of founder fraud that's slowly starting to pop up:

Startup raises a lot of money far ahead of their valuation

Founders effectively "give up" but keep paying themselves generously with the cash raised versus returning money to investors